This website uses cookies to enhance the user experience.
||
WA

Wenche Abelseth1970

Shareholdings
24
0
Norway Business roles
2

Roles

Boards

NameRoleTotal operating incomeTotal equityShares
W
WENCHE ABELSETH
Holder
-
-
-
N
NORDIC RECOMMERCE AS
Deputy Chair
-
-
-
Last update: Oct 3, 2025

Shares owned by Wenche Abelseth

NameShare classTotal operating incomeTotal equityShare
C
CARASENT ASA
Closed
NO0010123060
28,346,000
987,665,000
< 0.01 %
directly
F
FLYR AS
Closed
NO0010931900
125,939,000
163,919,000
< 0.01 %
directly
E
ENSURGE MICROPOWER ASA
NO0013186460
0
-34,498,000
< 0.01 %
directly
E
ELKEM ASA
NO0010816093
9,710,000,000
15,665,000,000
< 0.01 %
directly
V
VISTIN PHARMA ASA
NO0010734122
0
184,035,000
< 0.01 %
directly
A
AYFIE INTERNATIONAL AS
NO0012861683
0
8,770,197
< 0.01 %
directly
F
FJORD DEFENCE GROUP ASA
NO0010778095
-730,000
27,235,000
< 0.01 %
directly
O
ORKLA ASA
NO0003733800
292,000,000
67,318,000,000
< 0.01 %
directly
H
HEXAGON PURUS ASA
NO0010904923
101,478,000
2,700,801,000
< 0.01 %
directly
P
PEXIP HOLDING ASA
NO0010840507
0
1,265,489,000
< 0.01 %
directly
S
STOREBRAND ASA
NO0003053605
4,981,000,000
32,127,000,000
< 0.01 %
directly
NO0003021909
42,000
472,155,000
< 0.01 %
directly
K
KOMPLETT ASA
NO0011016040
0
2,718,000,000
< 0.01 %
directly
S
STRONGPOINT ASA
NO0010098247
14,486,000
406,698,000
< 0.01 %
directly
N
NEXT BIOMETRICS GROUP ASA
NO0010629108
9,451,000
361,701,000
< 0.01 %
directly
Y
YARA INTERNATIONAL ASA
NO0010208051
4,201,000,000
27,813,000,000
< 0.01 %
directly
P
POLIGHT ASA
NO0012535832
9,624,000
227,558,000
< 0.01 %
directly
E
ELLIPTIC LABORATORIES ASA
NO0010722283
133,343,000
317,393,000
< 0.01 %
directly
P
PCI BIOTECH HOLDING ASA
NO0010405640
0
43,986,000
< 0.01 %
directly
X
XXL AS
NO0013293142
0
1,494,000,000
< 0.01 %
directly
Z
ZELLUNA ASA
NO0010851603
0
81,006,000
< 0.01 %
directly
T
THOR MEDICAL ASA
NO0010597883
0
341,463,000
< 0.01 %
directly
C
CRAYON GROUP HOLDING AS
NO0010808892
0
1,907,000,000
< 0.01 %
directly
B
BORREGAARD ASA
NO0010657505
0
2,219,498,000
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025